Aadi Bioscience (AADI) News Today $2.98 -0.15 (-4.79%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Aadi Bioscience, Inc. (NASDAQ:AADI) Position Lowered by Jane Street Group LLCJane Street Group LLC lessened its holdings in Aadi Bioscience, Inc. (NASDAQ:AADI - Free Report) by 80.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,989 shares of the company's stock after seJanuary 16, 2025 | marketbeat.comAadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 136.0% in DecemberAadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 547,500 shares, a growth of 136.0% from the December 15th total of 232,000 shares. Currently, 2.7% of the shares of the stock are sold short. Based on an average daily volume of 322,600 shares, the days-to-cover ratio is currently 1.7 days.January 14, 2025 | marketbeat.comAadi Bioscience (NASDAQ:AADI) Shares Down 16.1% - What's Next?Aadi Bioscience (NASDAQ:AADI) Trading Down 16.1% - What's Next?January 14, 2025 | marketbeat.comAadi Bioscience Leads 3 Promising US Penny StocksDecember 23, 2024 | uk.finance.yahoo.comAadi Bioscience’s Strategic Agreements and Funding MovesDecember 21, 2024 | finance.yahoo.comAadi Bioscience stock soars on licensing and sale dealsDecember 20, 2024 | investing.comAadi Bioscience rockets 72% on key updatesDecember 20, 2024 | msn.comAadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE FinancingDecember 19, 2024 | prnewswire.comAadi Bioscience, Inc. (NASDAQ:AADI) Short Interest UpdateAadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the recipient of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 224,000 shares, a decrease of 12.7% from the November 15th total of 256,500 shares. Currently, 1.1% of the shares of the company are short sold. Based on an average daily trading volume, of 125,300 shares, the short-interest ratio is presently 1.8 days.December 15, 2024 | marketbeat.comAadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 8.8% in NovemberAadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 256,500 shares, a decrease of 8.8% from the October 31st total of 281,100 shares. Based on an average daily volume of 148,600 shares, the short-interest ratio is currently 1.7 days. Currently, 1.3% of the shares of the company are sold short.December 2, 2024 | marketbeat.comUS Penny Stocks Under $90M Market Cap To WatchNovember 12, 2024 | finance.yahoo.comBML Capital Management LLC Buys Shares of 2,000,000 Aadi Bioscience, Inc. (NASDAQ:AADI)BML Capital Management LLC bought a new stake in Aadi Bioscience, Inc. (NASDAQ:AADI - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,000,000 shares of the company'sNovember 12, 2024 | marketbeat.comAadi Bioscience Faces Potential Financial Strain from Securities Class Action RisksNovember 9, 2024 | markets.businessinsider.comAadi Bioscience Reports Q3 2024 Earnings and GrowthNovember 7, 2024 | markets.businessinsider.comAadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate UpdateNovember 6, 2024 | prnewswire.comAadi Bioscience to Report Third Quarter 2024 Results and Corporate UpdateOctober 30, 2024 | prnewswire.comAadi Bioscience CEO sells shares worth $18,796October 5, 2024 | investing.comAadi Bioscience (NASDAQ:AADI) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comDavid James Lennon Sells 9,689 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) StockOctober 4, 2024 | insidertrades.comWin for Perioperative Durvalumab in Muscle-Invasive Bladder CancerSeptember 17, 2024 | msn.comAadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $68,400.00 in StockSeptember 8, 2024 | insidertrades.comAadi Bioscience stock downgraded to Neutral, PT reduced following trial outcomeAugust 29, 2024 | uk.investing.comPiper Sandler Downgrades Aadi Bioscience (AADI)August 28, 2024 | msn.comHold Rating for Aadi Bioscience Amid Clinical Setbacks and Modest Revenue ProjectionsAugust 27, 2024 | markets.businessinsider.comAadi Bioscience downgraded to Neutral, shares fallAugust 27, 2024 | msn.comTD Cowen Downgrades Aadi Bioscience (AADI)August 22, 2024 | msn.comAadi Bioscience: Hold Rating Amidst Trial Discontinuation and Limited Growth ProspectsAugust 21, 2024 | markets.businessinsider.comAadi axes 80% of staff after registrational Phase II trial failsAugust 21, 2024 | finance.yahoo.comCancer Focused-Aadi Bioscience Stock Plunges As Solid Tumor Trial Falls Short Of ExpectationsAugust 21, 2024 | finance.yahoo.comWhy Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving PremarketAugust 21, 2024 | msn.comAadi Bioscience to Halt Tumor Treatment Trial, Preserve Cash Flow With Job CutsAugust 21, 2024 | marketwatch.comTD Cowen downgrades Aadi Bioscience (AADI) to a HoldAugust 21, 2024 | markets.businessinsider.comAadi Bioscience Provides PRECISION1 Trial and Corporate UpdatesAugust 20, 2024 | prnewswire.comAadi Bioscience Inc (3350.BE)August 13, 2024 | finance.yahoo.comAadi Bioscience Stock Hits 52-Week Low at $1.27 Amid Market ChallengesAugust 10, 2024 | investing.comAadi Bioscience, Inc. (AADI) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comAadi Bioscience (NASDAQ:AADI) Stock Quotes, Forecast and News SummaryAugust 10, 2024 | benzinga.comAadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate UpdateAugust 7, 2024 | prnewswire.comAadi Bioscience earnings preview: what to expectAugust 6, 2024 | markets.businessinsider.comInsider Selling: Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells 15,415 Shares of StockAugust 6, 2024 | insidertrades.comAadi Bioscience to Report Second Quarter 2024 Results and Corporate UpdateJuly 31, 2024 | prnewswire.com3 Russell 2000 Stocks to Sell in July Before They Crash & BurnJuly 5, 2024 | investorplace.comNeil Desai Sells 31,348 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) StockJuly 3, 2024 | insidertrades.comAadi Bioscience to Participate in the Jefferies Healthcare ConferenceMay 29, 2024 | prnewswire.comAadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 23, 2024 | prnewswire.comArcutis Biotherapeutics Shares Climb 24% on 1Q Revenue SurgeMay 15, 2024 | marketwatch.comAadi Bioscience, Inc. (NASDAQ:AADI) Analysts Are Cutting Their Estimates: Here's What You Need To KnowMay 11, 2024 | finance.yahoo.comAnalysts Just Made A Major Revision To Their Aadi Bioscience, Inc. (NASDAQ:AADI) Revenue ForecastsMay 10, 2024 | finance.yahoo.comArlo Technologies: Q1 Earnings SnapshotMay 9, 2024 | washingtonpost.comAadi Bioscience, Inc. (NASDAQ:AADI) Q1 2024 Earnings Call TranscriptMay 9, 2024 | insidermonkey.com Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Email Address AADI Media Mentions By Week AADI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AADI News Sentiment▼0.790.44▲Average Medical News Sentiment AADI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AADI Articles This Week▼31▲AADI Articles Average Week Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CMRX News Today YMAB News Today VYGR News Today LFVN News Today ITOS News Today AQST News Today IMMP News Today NGNE News Today OLMA News Today ATYR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AADI) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
